Fundz

Bolt Biotherapeutics acquires Prana Therapies

PUBLIC · BOLTOct 23, 2026

Acquiring Company

Bolt Biotherapeutics

Acquired Company

Prana Therapies

Redwood CityCaliforniaOtherBiotechnologyBiotechnology

Description

Bolt Biotherapeutics announced on October 23, 2026 its acquisition of Prana Therapies, Inc. in a stock-for-stock reverse merger. The deal is paired with a $120 million upfront private placement, with up to $60 million more from warrants, expected to fund operations into 2028. The combined company will advance PRA-216 and the INSPIRE pipeline.

Who to call at Bolt Biotherapeutics, and when

When Bolt Biotherapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Bolt Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bolt Biotherapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bolt Biotherapeutics

Location

900 CHESAPEAKE DRIVE

Redwood City, California, United States

About

Bolt Biotherapeutics is a Nasdaq-listed (BOLT) biotechnology company. It announced the acquisition of Prana Therapies alongside a $120 million concurrent private placement. The company will advance Prana's PRA-216 pipeline in inflammatory indications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bolt Biotherapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bolt Biotherapeutics's next move

Learn about Strategic plan

Frequently asked

Who acquired Prana Therapies?

Prana Therapies was acquired by Bolt Biotherapeutics, based in Redwood City. The deal was reported on October 23, 2026. Bolt Biotherapeutics is a Nasdaq-listed (BOLT) biotechnology company. It announced the acquisition of Prana Therapies alongside a $120 million concurrent private placement. Bolt Biotherapeutics is publicly traded (BOLT) and operates in Other.

When did Bolt Biotherapeutics acquire Prana Therapies?

Bolt Biotherapeutics's acquisition of Prana Therapies was reported on October 23, 2026. Bolt Biotherapeutics announced on October 23, 2026 its acquisition of Prana Therapies, Inc. in a stock-for-stock reverse merger. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Prana Therapies do?

Prana Therapies is the company acquired in this transaction. It is privately held, operating in Biotechnology, and is based in California.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.